results from venetoclax added to clad combo for older patients w/ #aml | tapan kadia, md | ash 2023
Published 9 months ago • 78 plays • Length 1:42
Download video MP4
Download video MP3
Similar videos
-
2:26
extending aml remissions with hypomethylating agents and venetoclax | tapan kadia, md | ash 2023
-
4:37
relaza2 results: azacitidine use in mds & aml | anne sophie kubasch, md | eha 2024
-
4:59
venetoclax plus clad/ldac and aza for older aml patients
-
21:51
virtual round table with md anderson part i - dr. tapan kadia - aml treatment & maintenance therapy
-
2:57
costs of venetoclax-obinutuzumab vs. btki in cll | scott huntington, md, mph, msc | ash 2023
-
4:41
acute myeloid leukemia survival rate and outlook
-
2:09:30
speciality update with cardiologists - april 2021
-
7:08
ash 2023 | karmma-3 trial: quality of life with idecabtagene vicleucel
-
6:31
real-world results from talquetamab and bispecific antibodies | carolina schinke, md | ash 2023
-
5:29
updates on teclistamab, talquetamab, and carvykti | mark wildgust, phd | ash 2022
-
3:09
caveat: venetoclax and high dose chemo for elderly aml
-
2:00
durvalumab plus danvatirsen for r/m hnscc: exciting scores data
-
1:23
tavr patient: kaja's story
-
4:41
thriving after pancreatic cancer | duke health
-
4:07
exciting novel aml treatment: venetoclax plus cobimetinib or idasanutlin in elderly patients
-
2:20
pancreatic cancer vaccine study yields hopeful results, reviewed by hopkins dr.
-
3:14
health check: world pancreatic cancer day
-
1:34
arcadia: evaluating durvalumab and cabozantinib in variant histology tumors
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia
-
1:48
emerging research and the evolution of treatment for metabolic associated steatohepatitis
-
6:16
precision medicine and the future of pancreatic cancer
Clip.africa.com - Privacy-policy